Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
4.260
+0.020 (0.47%)
At close: Nov 6, 2026, 4:00 PM EST
4.250
-0.010 (-0.23%)
After-hours: Nov 6, 2026, 7:52 PM EST
Cingulate Market Cap
Cingulate has a market cap or net worth of $61.95 million as of November 6, 2026. It is the 28,258th most valuable company in the world and the 4,421st biggest in the United States. Its market cap has increased by 189.27% in one year.
Market Cap
61.95M
Enterprise Value
39.84M
1-Year Change
189.27%
Global Rank
Country Rank
#4,421 United States
Category
ChartMarket Cap Chart
Since the IPO on December 8, 2021, Cingulate's market cap has decreased from $64.29M to $61.95M, a decrease of -3.64%. That is a compound annual growth rate of -0.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 61.95M | 111.24% |
| Dec 31, 2025 | 29.33M | 80.15% |
| Dec 31, 2024 | 16.28M | 127.09% |
| Dec 29, 2023 | 7.17M | -36.62% |
| Dec 30, 2022 | 11.31M | -63.77% |
| Dec 31, 2021 | 31.21M | -51.44% |
| Dec 8, 2021 | 64.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Acrivon Therapeutics | 66.85M |
| Champions Oncology | 66.25M |
| Coya Therapeutics | 65.92M |
| Nutriband | 65.28M |
| Conexeu Sciences | 65.05M |
| MAIA Biotechnology | 62.95M |
| Fortress Biotech | 61.03M |
| Cognition Therapeutics | 60.31M |